|
Market Closed -
Other stock markets
|
Pre-market 01:30:18 | |||
| 27.20 EUR | 0.00% |
|
27.40 | +0.74% |
| 07-09 | Solaris Energy Infrastructure to Join S&P SmallCap 600 | MT |
| 07-08 | Catalyst Pharmaceuticals, Inc. Announces Board Changes | CI |
Company Valuation: Catalyst Pharmaceuticals, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 698.1 | 1,936 | 1,792 | 2,489 | 2,869 | 3,853 | - | - |
| Change | - | 177.28% | -7.42% | 38.9% | 15.25% | 34.29% | - | - |
| Enterprise Value (EV) | 506.8 | 1,637 | 1,655 | 1,972 | 2,160 | 3,853 | 3,853 | 3,853 |
| Change | - | 223.05% | 1.05% | 19.17% | 9.53% | 78.39% | 0% | 0% |
| P/E | 18.3x | 24.8x | 26.7x | 15.9x | 13.9x | 16.1x | 13.1x | 12.2x |
| PBR | 3.53x | 6.9x | 4.93x | 3.47x | 3x | - | - | - |
| PEG | - | 0x | -1.7x | 0x | 0.5x | 1x | 0.6x | 1.69x |
| Capitalization / Revenue | 4.96x | 9.04x | 4.5x | 5.06x | 4.87x | 6.06x | 5.37x | 4.86x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 6.06x | 5.37x | 4.86x |
| EV / EBITDA | - | - | - | 0x | 0x | 10.6x | 9.48x | 9x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 12.1x | 10x | 9.33x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 17.4x | 14.2x | 12.3x |
| FCF Yield | 8.5% | 5.99% | 8% | 9.61% | 7.27% | 5.74% | 7.03% | 8.15% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.37 | 0.75 | 0.63 | 1.31 | 1.68 | 1.953 | 2.407 | 2.58 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 140.8 | 214.2 | 398.2 | 491.7 | 589 | 636.2 | 717.9 | 792.2 |
| EBITDA 1 | - | - | - | 255.1 | 320.4 | 363.3 | 406.5 | 428 |
| EBIT 1 | 52.38 | 101.8 | 86.81 | 195.1 | 257.8 | 318 | 385.3 | 412.8 |
| Net income 1 | 39.48 | 83.08 | 71.41 | 163.9 | 214.3 | 231.1 | 316.2 | 320 |
| Net Debt | -191.3 | -298.4 | -137.6 | -517.6 | -709.2 | - | - | - |
| Reference price 2 | 6.77 | 18.60 | 16.81 | 20.87 | 23.34 | 31.47 | 31.47 | 31.47 |
| Nbr of stocks (in thousands) | 103,118 | 104,071 | 106,611 | 119,273 | 122,912 | 122,420 | - | - |
| Announcement Date | 3/16/22 | 3/15/23 | 2/28/24 | 2/26/25 | 2/25/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 17.29x | 3.79x | 10.17x | 0.58% | 67.96B | |
| 27.02x | 5.55x | 16.28x | 0.59% | 54.4B | |
| 32.87x | 11.12x | 21.25x | -.--% | 40.63B | |
| -46.91x | 3.29x | 9.71x | 3.27% | 41.74B | |
| 30.31x | 3.47x | 10.96x | -.--% | 29.37B | |
| -8.83x | 12.88x | -7.91x | -.--% | 30.38B | |
| 17.2x | 3.3x | 10.01x | -.--% | 23.68B | |
| 57.92x | 6.05x | 41.38x | -.--% | 19.15B | |
| 26.74x | 5.48x | 14.72x | -.--% | 17.14B | |
| Average | 17.07x | 6.10x | 14.06x | 0.49% | 36.05B | |
| Weighted average by Cap. | 14.24x | 5.95x | 12.97x | 0.64% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CPRX Stock
- CN2 Stock
- Valuation Catalyst Pharmaceuticals, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
